Perceptions and Ultrasound Literacy for Sound Volume Management
NCT ID: NCT07237347
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2025-12-01
2026-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasonography for Prediction of Extubation Success: a Holistic Approach
NCT04196361
Lung Ultrasound-Guided Fluid Deresuscitation in ICU Patients
NCT05188092
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
NCT04379544
Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients
NCT05054270
Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care Patients
NCT01857674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will complete an online questionnaire via REDCap, covering demographics, professional background, ultrasound training, knowledge and experience with ultrasound for volume management and venous congestion, as well as institutional factors and suggestions for improvement. The survey will be distributed to physicians working in ICUs at multiple Swiss hospitals, including the University Hospital Basel, Kantonsspital Aarau, Inselspital Bern, Spitalzentrum Biel, and Triemlispital Zürich. Participation is voluntary, and informed consent will be obtained electronically at the start of the questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU staff
physicians working in ICUs in Switzerland
Quastionnaire
physicians working in ICUs will complete a questionnaire through REDcap
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quastionnaire
physicians working in ICUs will complete a questionnaire through REDcap
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* working in Switzerland
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregor Loosen, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
am25Loosen;Req-2025-00684
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.